Pharmaceuticals (85) | Compensation Agreements (85)
Browse by Company
-
ACELRX PHARMACEUTICALS INC (4)
-
Aclaris Therapeutics, Inc. (4)
-
ALIMERA SCIENCES INC (1)
-
Amag Pharmaceuticals (2)
-
Amneal Pharmaceuticals, Inc. (2)
-
Amphastar Pharma (1)
-
APRICUS BIOSCIENCES, INC. (2)
-
Assertio Therapeutics, Inc (1)
-
Bristol-Myers Squibb (1)
-
Cara Therapeutics, Inc. (2)
-
CARDAX, INC. (1)
-
CNS Pharmaceuticals, Inc. (1)
-
CymaBay Therapeutics, Inc. (1)
-
Endo International plc (1)
-
Evofem Biosciences, Inc. (1)
-
Evoke Pharma Inc (3)
-
Fulcrum Therapeutics, Inc. (2)
-
Horizon Pharma plc (2)
-
Intersect ENT, Inc. (2)
-
Intra-Cellular Therapies, Inc. (1)
-
Iterum Therapeutics plc (1)
-
Jazz Pharmaceuticals plc (1)
-
KEMPHARM, INC (4)
-
Lannett Company, Inc. (1)
-
Level Brands, Inc. (1)
-
Lyra Therapeutics, Inc. (1)
-
Merck (1)
-
Milestone Pharmaceuticals Inc. (1)
-
MJ Holdings, Inc. (1)
-
MyoKardia Inc (3)
-
Neos Therapeutics, Inc. (2)
-
NGM BIOPHARMACEUTICALS INC (1)
-
NovaBay Pharmaceuticals, Inc. (1)
-
Novan, Inc. (2)
-
OMEROS CORP (1)
-
Pacira Pharmaceuticals, Inc. (1)
-
Paratek Pharmaceuticals, Inc. (2)
-
Pfizer (2)
-
Phathom Pharmaceuticals, Inc. (2)
-
PLIANT THERAPEUTICS, INC. (3)
-
REATA PHARMACEUTICALS INC (4)
-
Revance Therapeutics, Inc. (5)
-
Satsuma Pharmaceuticals, Inc. (1)
-
SCYNEXIS INC (1)
-
Strongbridge Biopharma plc (2)
-
Trevi Therapeutics, Inc. (2)
-
Wave Life Sciences Ltd. (2)
-
XERIS PHARMACEUTICALS INC (1)
Recent Contracts
-
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
(Revance Therapeutics, Inc., Filed With SEC on May 10, 2021)
-
2021 Non-Employee Director Compensation Plan
(NovaBay Pharmaceuticals, Inc., Filed With SEC on May 6, 2021)
-
Non-Employee Director Compensation Policy
(APRICUS BIOSCIENCES, INC., Filed With SEC on April 30, 2021)
-
Non-Employee Director Compensation Policy
(Paratek Pharmaceuticals, Inc., Filed With SEC on March 29, 2021)
-
Non-Employee Director Compensation Policy
(Trevi Therapeutics, Inc., Filed With SEC on March 25, 2021)
-
Amended and Restated Non-Employee Director Compensation Policy
(Iterum Therapeutics plc, Filed With SEC on March 16, 2021)
-
Non-Employee Director Compensation Policy
(ACELRX PHARMACEUTICALS INC, Filed With SEC on March 15, 2021)
-
Sixth Amended and Restated Non-Employee Director Compensation Policy
(KEMPHARM, INC, Filed With SEC on March 12, 2021)
-
Non-Employee Director Compensation Policy, as Amended and Restated Effective January 27, 2021
(Evoke Pharma Inc, Filed With SEC on March 11, 2021)
-
Amended and Restated Non-Employee Director Compensation Policy
(Evofem Biosciences, Inc., Filed With SEC on March 4, 2021)
